Does BPC-157 Help Wrist Tendonitis and De Quervain's?

No study has tested BPC-157 in people with wrist tendonitis or De Quervain tenosynovitis. In rats, BPC-157 helped cut Achilles tendons heal stronger within 14 days, which is why people with sore wrists are asking about it. For De Quervain tenosynovitis, a review of trials in JAMA Network Open found that a steroid injection plus a thumb splint worn for 3 to 4 weeks should be the first treatment. BPC-157 is a frontier option some people try for slow, overuse-type tendon pain. Bring it to your clinical team knowing what the rat studies show, what FDA has said and what has never been tested.

Has BPC-157 Been Tested on Wrist Tendonitis or De Quervain's?

No. When FDA reviewed BPC-157 for its July 2026 pharmacy compounding advisory committee meeting, it found no studies that gave BPC-157 to people by mouth, as an injection under the skin, as a nasal spray or as a skin cream.

Published reports of BPC-157 in people describe compounded BPC-157 used for knee pain, interstitial cystitis (a painful bladder condition) and ulcerative colitis. None covers the wrist.

The only randomized trial FDA described included 53 people with mild to moderate ulcerative colitis. They used BPC-157 enemas every day for 2 weeks. Their disease score dropped 3.2 points, compared with 1.6 points for the placebo group. The difference between the groups was not statistically clear.

The case for BPC-157 on your wrist rests on animal tendon studies. Those findings are real, but they do not prove it will work on your wrist. Go in knowing that.

Why Do People Try BPC-157 for Tendon Pain?

The rat tendon results are consistent. In rats with a cut Achilles tendon, daily BPC-157 made the healing tendon stronger over 14 days, according to a 2019 review in Cell and Tissue Research. The gap in the tendon was smaller and shallower, and the treated rats used the leg better than untreated rats.

Under the microscope, the treated tendons had more fibroblasts (the cells that rebuild tendon) and better collagen fibers. Rat studies also found healing in ligaments and muscle. Results were positive whether BPC-157 was given by mouth, as a cream or as an injection.

The same review found that every BPC-157 healing study so far was positive. Most were done in small rodents by a handful of research groups, and the effect has yet to be confirmed in humans.

People are also posting their own experiences. One man in r/Peptides had wrist and forearm pain from typing and described his desk job: "I work a desk job and needless to say spend all day doing keystrokes." One week into BPC-157, he wrote: "Ive noticed some changes in my body, like muscle pain and just overall how i feel on the daily. Is this normal?" Bring new symptoms like that to your clinical team, not a forum.

A 30-year-old in r/Peptides had six years of shoulder pain. He described a 40-day run of BPC-157, before adding TB-500 for what he called the "Wolverine Stack." He wrote: "By week two, I was going about my day and suddenly realized the shoulder didn't hurt." At the end, he wrote: "Finished that 40-day run and I'd say about 60–70% of the pain had vanished, though I still had the odd bad morning." His post was about his shoulder and his own result.

What Works Best for De Quervain's Tenosynovitis?

De Quervain tenosynovitis affects the two tendons on the thumb side of the wrist. It seems to come more from overuse wear and a thickened tendon sheath than from inflammation, according to the JAMA Network Open review.

If your wrist still hurts after a splint and a shot, or you want to talk through frontier options, tell your clinical team what you have tried and how long the pain has lasted.

Is BPC-157 Safe, and Can I Get It Prescribed?

FDA says there is not enough clinical safety information to describe BPC-157's safety. Injected under the skin or used as a nasal spray, it may carry a significant risk of an immune reaction, and impurities in the peptide could make that risk worse. Ask your clinical team what to watch for.

Compounded medicines are made to order by a pharmacy, and they are not FDA approved. That means FDA does not review them for safety, effectiveness or manufacturing quality before they are sold.

BPC-157 is not on FDA's list of bulk substances that pharmacies can compound from. At its July 2026 advisory committee meeting, FDA proposed that BPC-157 not be added to that list.

If you compete in a drug-tested sport, the World Anti-Doping Agency's 2026 Prohibited List bans BPC-157 at all times, in and out of competition.

Hot or Nothing offers BPC-157 through plans with our clinical team. Your clinical team decides whether it fits your wrist, your history and your goal.

You want to use your hand again without wincing at your keyboard or your phone. Take the quiz to tell our clinical team about your wrist and what you have tried, and see whether BPC-157 fits your plan.